The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients

M.V. Zhuravleva

Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia, Moscow, Russia

A.B. Prokofiev

I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Private Dermatovenerologic Clinic, Svidnik, Slovak Republic;
Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of the Russian Federation, Moscow, Russia

V.V. Arkhipov

Research center for examination of medical devices, Moscow, Russia

S.Yu. Serebrova

I.M. Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russia, Moscow, Russia, 119991;
Scientific Center for Expertise of Medical Products, Ministry of Healthcare of the Russia, Moscow, Russia, 127051

G.I. Gorodetskaya

O.A. Demidova

Research center for examination of medical devices, Moscow, Russia

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(3): 92–96

The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients

Authors:

M.V. Zhuravleva, A.B. Prokofiev, V.V. Arkhipov, S.Yu. Serebrova, G.I. Gorodetskaya, O.A. Demidova

More about the authors

DOI: 10.17116/jnevro202012003192

Read: 7002 times

Open to cite this article

Zhuravleva MV, Prokofiev AB, Arkhipov VV, Serebrova SYu, Gorodetskaya GI, Demidova OA. The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(3):92‑96. (In Russ., In Engl.).
https://doi.org/10.17116/jnevro202012003192

Close metadata

Recommended articles:

Modern technologies for surgical treatment of patients with congenital epidermolysis bullous with hand deformities. Pirogov Russian Journal of Surgery. 2025;(10):95-95

Rehabilitation of persons with alcohol dependence occurred in middle and elderly age and complicated by secondary organic mental disorders in elderly age. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):42-50

Improving the quality of life and the possibility of pathogenetic therapy in adult patients with cerebral palsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):75-84

Cognitive dysfunction in children with nervous system diseases: modern approaches to diagnosis and treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):69-79

Experience in the use of electro- and radio-surgical apparatus with no-therapy in the combined treatment of decubital ulcers in comorbid patients of multidisciplinary hospitals, including ICUs. Pirogov Russian Journal of Surgery. 2025;(11):86-93

Correction of postoperative metabolic disorders after radiofrequency ablation for atrial fibrillation. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):680-684

Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):86-99

Brain aging: molecular targets of geroprotection and prevention strategies. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):132-139

Current possibilities of physiotherapy rehabilitation programs in the treatment of postoperative pain after surgical treatment of complex anal fistulas. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):28-34

Extraction and analysis of cardiorespiratory exercise test data for personalization and monitoring of rehabilitation process effectiveness. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):66-71

The analysis of the clinical efficacy and safety of ethylmethylhydroxypyridine succinate (mexidol) in the complex of rehabilitation measures in patients after ischemic stroke (IS) shows that course treatment with mexidol improves the recovery of neurological functions, decreases neurological deficit, cognitive disorders, including memory impairment, and manifestations of asthenic syndrome, increases the level of social adaptation and improves the psycho-emotional state of patients, reduces spasticity, increases motor and speech activity, praxis, reliably eliminates the ignoring syndrome. There is a decrease in the level of total cholesterol and low-density b-lipoproteins in the blood, and decrease in the severity of hypercoagulation. The results of the studies have convincingly shown the efficacy of mexidol at all stages of rehabilitation treatment of patients with IS.

Keywords:

ethylmethylhydroxypyridine succinate

Authors:

M.V. Zhuravleva

Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia, Moscow, Russia

A.B. Prokofiev

V.V. Arkhipov

Research center for examination of medical devices, Moscow, Russia

S.Yu. Serebrova

G.I. Gorodetskaya

O.A. Demidova

Research center for examination of medical devices, Moscow, Russia

List of references:

Gusev EI, Martynov MYu, Kamchatnov PR. Ishemicheskij insul’t. Sovremennoe sostoyanie problemy. Doktor ru. 2013;5:83:7-12. (In Russ.).
Gusev EI, Skvorczova VI, Stakhovskaya LV. Epidemiology of stroke in Russia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Insul`t. 2003;8:4–9. (In Russ.).
Gusev EI, Skvorcova VI. Ishemiya golovnogo mozga. M: Medicina. 2001. (In Russ.).
Kamchatnov PR, Tyazhel`nikov AA, Osmaeva ZKh, Chugunov AV. Nejrometabolicheskie preparaty` v kompleksnoj terapii czerebrovaskulyarny`kh zabolevanij. Vrach. 2018;29(11):59–63. (In Russ.). https://doi.org/10.29296/25877305-2018-11-12
Karpikova NI, Peteryuhina AA. Primenenie preparata «Meksidol®» dlya lecheniya bol’nyh s zabolevaniyami sosudov golovnogo mozga. Byulleten’ eksperimental’noj biologii i mediciny. 2006;(supl 1):32-33. (In Russ.).
Kuznecova SM, Kuznecov VV, Yurchenko FV. Meksidol v reabilitacii bol’nyh pozhilogo vozrasta, perenesshih insul’t. Farmateka. 2009;15:105-108. (In Russ.).
Tanashyan MM, Lagoda OV, Antonova KV. Chronic cerebrovascular diseases on the background of metabolic syndrome: new approaches to treatment. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2012;112(11):21-26. (In Russ.).
Abylaeva MT. Primenenie preparata meksidol v kompleksnom lechenii postinsul’tnyh rasstrojstv. Vestnik KAZNMU. 2012;2:37-38. (In Russ.).
Koval’chuk VV. Nejrometabolicheskaya terapiya kak sredstvo vtorichnoj profilaktiki insul’ta. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;114(3):24-28. (In Russ.).
Koval’chuk VV. Effect of Mexidol on neurological deficits, social adaptation, and non-eclectic and «repulsive» syndromes in patients after stroke. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2011;12(2):52-57. (In Russ.).
Kuznecova EB, Salina EA, Sholomov II. Possibility of correction of cognitive disorders in the course of complex treatment of patients with the consequences of a brain infarction. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2015;115(11):103-106. (In Russ.).
Kuznecov VV, Yurchenko FV. Features of the effect of Mexidol on the functional state of the Central nervous system in patients who have suffered a stroke. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2012;6:18-20. (In Russ.).
Kispaeva TT. Preventive and therapeutic correction of the formation and progression of cognitive deficits in stroke patients. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2013;113(7):76-79. (In Russ.).
Koval’chuk VV, Skoromets AA. Vozmozhnosti Meksidola pri vosstanovlenii patsientov posle insul’ta. Medlajn-ehkspress. 2009;4-5(203):4-6. (In Russ.).